Norma Beauchamp is the former President and Chief Executive Officer of Cystic Fibrosis Canada. An accomplished business and non-profit leader, she has three decades of senior leadership experience in Canada and globally based in Germany, including executive positions at Bayer Inc. and Sanofi Canada.
Ms. Beauchamp currently serves on the boards of Extendicare, Aurora Cannabis Inc, Accerta, HLS Therapeutics, and Dialogue Health Technologies. She volunteers her time as a member and Ambassador of Women Get on Board. BMO recognized her contributions to the boardroom by making her an honoree in its annual Celebrating Women on Boards in 2021.
Ms. Beauchamp completed the University of Toronto's Rotman School of Management Director's Education Program (ICD.D) and graduated from Bishop's University with a Bachelor of Business Administration.
Ms. Beauchamp was appointed to the NRC Council in June 2019. She was re-appointed for a second mandate in September 2022.